Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mamiya

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Therapeutic Drug Monitoring|April 11, 2001
P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphismA Hadama, I Ieiri, T Morita, et al.
Therapeutic Drug Monitoring|June 13, 2000
Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysisI Ieiri, H Tainaka, T Morita, et al.
Pharmacogenetics|March 30, 2000
Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locusJ Imai, I Ieiri, K Mamiya, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjectsI Ieiri, T Kubota, A Urae, et al.
British Journal of Clinical Pharmacology|April 1, 1997
Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in JapaneseI Ieiri, K Mamiya, A Urae, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Therapeutic Drug Monitoring|April 11, 2001
P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphismA Hadama, I Ieiri, T Morita, et al.
Therapeutic Drug Monitoring|June 13, 2000
Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysisI Ieiri, H Tainaka, T Morita, et al.
Pharmacogenetics|March 30, 2000
Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locusJ Imai, I Ieiri, K Mamiya, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjectsI Ieiri, T Kubota, A Urae, et al.
British Journal of Clinical Pharmacology|April 1, 1997
Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in JapaneseI Ieiri, K Mamiya, A Urae, et al.
Pageof 4